Literature DB >> 4589131

Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.

M W Eklund, F T Poysky.   

Abstract

These studies show that Clostridium botulinum types C and D cultures can be cured of their prophages and converted to either type C or D depending on the specific phage used. Strains of types C and D were cured of their prophages and simultaneously ceased to produce their dominant toxins designated as C(1) and D, respectively. Cured nontoxigenic cultures derived from type C strain 162 were sensitive to the phages from the toxigenic type C strain 162 and type D strain South African. When cured nontoxigenic cultures derived from strain 162 were infected with the tox(+) phages from the 162 strain of type C and the South African strain of type D, they then produced toxin neutralized by types C and D antisera, respectively. Cured nontoxigenic cultures isolated from the type D South African strain were only sensitive to the parent phage, and, when reinfected with the tox(+) phage, they produced toxin neutralized by type D antiserum. Type C strain 153 and type D strain 1873, when cured of their respective prophages, also ceased to produce toxins C(1) and D, but, unlike strain 162 and the South African strain, they continued to produce a toxin designated as C(2). When the cured cultures from strains 153 and 1873 were infected with the tox(+) phage from type D strain 1873, the cultures simultaneously produced toxin that was neutralized by type D antiserum. When these cured cultures were infected with the tox(+) phage from type C strain 153, the cultures produced toxin that was neutralized by type C antiserum. These studies with the four strains of C. botulinum confirm that the toxigenicity of types C and D strains requires the continued participation of tox(+) phages. Evidence is presented that types C and D cultures may arise from a common nontoxigenic strain.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4589131      PMCID: PMC380000          DOI: 10.1128/am.27.1.251-258.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  21 in total

1.  Lysogeny in staphylococci.

Authors:  J E BLAIR; M CARR
Journal:  J Bacteriol       Date:  1961-12       Impact factor: 3.490

2.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

3.  Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae.

Authors:  V J FREEMAN
Journal:  J Bacteriol       Date:  1951-06       Impact factor: 3.490

4.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

5.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

6.  Bacteriophages of Clostridium botulinum.

Authors:  C E Dolman; E Chang
Journal:  Can J Microbiol       Date:  1972-01       Impact factor: 2.419

7.  [A bacteriophage in a culture of Cl. botulinum type C].

Authors:  G Vinet; L Berthiaume; V Fredette
Journal:  Rev Can Biol       Date:  1968-03

8.  Bacteriophages of Clostridium botulinum.

Authors:  K Inoue; H Iida
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

9.  Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States.

Authors:  M W Eklund; F T Poysky; D I Wieler
Journal:  Appl Microbiol       Date:  1967-11

10.  Enrichment, isolation, and cultural characteristics of marine strains of Clostridium botulinum type C.

Authors:  W P Segner; C F Schmidt; J K Boltz
Journal:  Appl Microbiol       Date:  1971-12
View more
  28 in total

1.  Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Tsuzuki; K Kimura; N Fujii; N Yokosawa; T Indoh; T Murakami; K Oguma
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 3.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 4.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

5.  Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.

Authors:  M W Eklund; F T Poysky; L M Mseitif; M S Strom
Journal:  Appl Environ Microbiol       Date:  1988-06       Impact factor: 4.792

6.  Horizontal gene transfer of toxin genes in Clostridium botulinum: Involvement of mobile elements and plasmids.

Authors:  Hanna Skarin; Bo Segerman
Journal:  Mob Genet Elements       Date:  2011-09-01

7.  Production of toxin by Clostridium botulinum type A strains cured by plasmids.

Authors:  M J Weickert; G H Chambliss; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1986-01       Impact factor: 4.792

8.  Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.

Authors:  M W Eklund; F T Poysky; M E Peterson; J A Meyers
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D.

Authors:  D Hauser; M Gibert; M W Eklund; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.